ACS study: Pandemic reduced breast, cervical, colorectal cancer screenings by millions in 2020

NCCN awards go to Green, Kumar, Black, and the COVID-19 Vaccination Advisory Committee

Darcie Green, Shaji K. Kumar, Donna Black, and the NCCN COVID-19 Vaccination Advisory Committee received of the 2024 National Comprehensive Cancer Network awards.

April 19, 2024

Vol.50 No.16

Clinical Roundup

PRECEDE study points to screening method for pancreatic cancer

Research published in April in the Journal of the National Comprehensive Cancer Network showcases the feasibility of improving early detection and prevention for pancreatic cancer.

April 19, 2024

Vol.50 No.16

Clinical Roundup

Urine test improves non-invasive detection of prostate cancer

A urine test that measures 18 genes associated with prostate cancer provides higher accuracy for detecting clinically significant cancers than PSA and other existing biomarker tests, according to a study published April 18 in JAMA Oncology.

April 19, 2024

Vol.50 No.16

Clinical Trials & Tribulations

A new standard in cancer care: Integrated screening, stepped collaborative care for common and distressing symptoms

Over 18 million people are diagnosed with cancer in the United States and approximately 50% report clinical levels of depression and/or anxiety, pain, and/or fatigue. xxx:more

ACS celebrates Black leaders whose contributions shaped health equity in cancer

In an article for the Cancer History Project, the American Cancer Society and the American Cancer Society Cancer Action Network celebrate six trailblazing Black leaders and pioneers who have made a lasting impact on health equity in oncology.

April 05, 2024

Vol.50 No.14